17-81809875-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000160.5(GCGR):c.154C>A(p.Pro52Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000332 in 1,535,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000160.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GCGR | NM_000160.5 | c.154C>A | p.Pro52Thr | missense_variant | 3/14 | ENST00000400723.8 | NP_000151.1 | |
GCGR | XM_006722277.2 | c.154C>A | p.Pro52Thr | missense_variant | 3/14 | XP_006722340.1 | ||
GCGR | XM_017024446.2 | c.148C>A | p.Pro50Thr | missense_variant | 3/14 | XP_016879935.1 | ||
GCGR | XM_011523539.2 | c.-73C>A | 5_prime_UTR_variant | 1/12 | XP_011521841.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GCGR | ENST00000400723.8 | c.154C>A | p.Pro52Thr | missense_variant | 3/14 | 1 | NM_000160.5 | ENSP00000383558.3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152260Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000706 AC: 1AN: 141544Hom.: 0 AF XY: 0.0000132 AC XY: 1AN XY: 75810
GnomAD4 exome AF: 0.0000340 AC: 47AN: 1383698Hom.: 0 Cov.: 31 AF XY: 0.0000366 AC XY: 25AN XY: 682808
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152260Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74398
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 12, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with GCGR-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.002%). This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 52 of the GCGR protein (p.Pro52Thr). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at